World's Best Scientists 2026 revealed!
Catherine Thieblemont

Catherine Thieblemont

D-Index & Metrics

Medicine

D-Index
103
Citations
42093
World Ranking
7318
National Ranking
225

Overview

Catherine Thieblemont is a researcher affiliated with Université Paris Cité in France. Their primary field of study is Medicine, with a strong focus on subfields such as Pathology and Forensic Medicine, Oncology, Genetics, Immunology, and Molecular Biology.

Their research topics include:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • CNS Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Acute Lymphoblastic Leukemia research
  • Monoclonal and Polyclonal Antibodies Research

They have contributed to several recent papers, including:

  • Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial, 2021, Nature Medicine
  • Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial, 2022, Journal of Clinical Oncology
  • Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma, 2020, Blood Advances
  • Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA), 2021, Annals of Oncology
  • A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma, 2022, Nature Medicine

The researcher collaborates frequently with other scientists in their field. Notable co-authors include:

  • Olivier Casasnovas
  • Franck Morschhauser
  • Emmanuel Bachy
  • Steven Le Gouill
  • Roch Houot

Their publications have appeared in several prominent journals, notably:

  • Blood
  • Hematological Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • HemaSphere

Best Publications

  • Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

    Bertrand Coiffier;Catherine Thieblemont;Eric Van Den Neste;Gérard Lepeu

  • Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

    Hervé Avet-Loiseau;Michel Attal;Philippe Moreau;Catherine Charbonnel

  • Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation.

    Philippe Colombat;Gilles Salles;Nicole Brousse;Pitahey Eftekhari

  • Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed

    Catherine Thieblemont;Françoise Berger;Charles Dumontet;Isabelle Moullet

  • Treatment of Older Patients with Mantle-Cell Lymphoma

    H. C. Kluin-Nelemans;Eva Hoster;Olivier Hermine;J. Walewski

  • Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

    Frédéric Peyrade;Fabrice Jardin;Catherine Thieblemont;Antoine Thyss

  • Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

    E. Zucca;A. Conconi;T.I. Mughal;A.H. Sarris

  • Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients.

    Catherine Thieblemont;Yves Bastion;Francoise Berger;Claire Rieux

  • Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

    Anas Younes;Laurie H. Sehn;Peter Johnson;Pier Luigi Zinzani

  • Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

    Annarita Conconi;Giovanni Martinelli;Catherine Thiéblemont;Andrés J M Ferreri

  • Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

    Olivier Hermine;Olivier Hermine;Eva Hoster;Jan Walewski;André Bosly

  • Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.

    Arnaud Jaccard;Nathalie Gachard;Benoit Marin;Sylvie Rogez

  • Primary thyroid lymphoma is a heterogeneous disease.

    C. Thieblemont;A. Mayer;C. Dumontet;Y. Barbier

  • Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults

    O. Hequet;Q.H. Le;I. Moullet;E. Pauli

  • Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

    Sandy Amorim;Anastasios Stathis;Mary Gleeson;Sunil Iyengar

  • Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

    Steven Le Gouill;Catherine Thieblemont;Lucie Oberic;Anne Moreau

  • The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study

    Catherine Thieblemont;Josette Briere;Nicolas Mounier;Hans-Ullrich Voelker

  • Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients

    Françoise Berger;Pascale Felman;Catherine Thieblemont;Thierry Pradier

  • ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

    M. Dreyling;C. Thieblemont;A. Gallamini;L. Arcaini

  • Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial

    Richard Delarue;Hervé Tilly;Nicolas Mounier;Tony Petrella

Frequent Co-Authors

Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
Hervé Tilly
Hervé Tilly Grenoble Alpes University
Bertrand Coiffier
Bertrand Coiffier Centre Hospitalier Lyon Sud
Corinne Haioun
Corinne Haioun Paris-Est Créteil University
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Olivier Casasnovas
Olivier Casasnovas Grenoble Alpes University
Martin Dreyling
Martin Dreyling Ludwig-Maximilians-Universität München
Philippe Gaulard
Philippe Gaulard Université Paris Cité
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Pier Luigi Zinzani
Pier Luigi Zinzani University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA can open doors to diverse healthcare roles beyond traditional medical school pathways. Many students choose to boost their credentials or shift specialties through flexible online degrees. For those seeking leadership positions in hospitals or clinics, enrolling in a healthcare administration accelerated degree is one of the most efficient routes to advancement.

Nurses wanting to expand their scope of practice may consider an rn to np bridge program. These programs allow registered nurses to become nurse practitioners with a streamlined curriculum. Additionally, if you’re interested in dietary health and preventative care, earning the best online nutrition degree can lead to careers in nutrition counseling, public health, and wellness coaching.

Aspiring healthcare executives should also explore accredited mha programs online, as these degrees can open up senior roles in healthcare management. Exploring these alternative online degrees allows prospective students to tailor their education to their career goals while enjoying the flexibility of remote learning.

Best Scientists Citing Catherine Thieblemont

Trending Scientists